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Abstract Due to their young age young stroke survivors
have to cope with a dramatic impact on their life for the
decades to come. We investigated the sex-specific very
long-term functional outcome after transient ischemic
attack (TIA) and ischemic stroke (IS) in adults aged
18–50 years. This study is part of a cohort study among
619 first-ever young ischemic stroke patients, admitted to
our department between January 1, 1980 and November 1,
2010. Functional outcome was assessed during follow-up
in 2009–2011 and in 2014–2015 with the modified Rankin
Scale (mRS) and instrumental Activities of Daily Living
scale (iADL). Risk factors for a poor functional outcome
(mRS[ 2 and iADL\ 8) were calculated by logistic
regression analysis. After a mean follow-up of 13.9 (SD
8.2) years, 24.5 % of TIA patients and 44.7 % of IS
patients had a poor functional outcome (mRS[ 2). When
assessing the survivors, 15.2 % of TIA patients and 22.9 %
of IS patients had a poor outcome as assessed by iADL.
The strongest baseline predictors of poor outcome were
female sex (OR 2.7, 95 % CI 1.5–5.0) and baseline NIHSS
(OR 1.1, 95 % CI 1.1–1.2 per point increase). In conclu-
sion, 14 years after an ischemic cerebrovascular event in
young adults, one out of five IS survivors and one out of ten
TIA survivors is still dependent in daily life, with a two to
threefold higher risk of a poor outcome in women. This
includes a period of life, during which important decisions
regarding work and family life have to be made.
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Introduction
The proportion of strokes occurring in young adults has
increased over the past decade up to almost 20 % of all
strokes [1]. At a young age stroke has a major impact on
psychological and social functioning, since in general at
this age people are active participants in the community.
Consequently, uncertainty about their long-term functional
outcome may affect patients’ choices in personal and
occupational issues [2].
Recently, we have shown that the functional prognosis
of young stroke patients is worse than previously assumed.
On average 10 years after an ischemic stroke (IS), 1 out of
8 survivors is dependent in daily life with an even higher
proportion dependent with increasing follow-up duration
[3]. Also, we found that a substantial proportion of the
patients deteriorated from their modified Rankin Scale
(mRS) immediately after stroke compared with their mRS
at follow-up.
As patients, their caregivers and health professionals
rank prognosis after stroke among their top 10 priorities
with regards to life after stroke [4], we wanted to investi-
gate whether post-stroke recovery is still possible, even
after 10 years of follow-up or longer. As women are
overrepresented among the younger (\30 years) stroke
survivors [5] and prognosis among female stroke victims in
general is known to be poorer [6] we explicitly wanted to
investigate the sex-specific very long-term prognosis. In
addition, we aimed to evaluate which determinants pre-
dicted the risk of a poor very long-term functional outcome
and the changes over time therein.
Methods
This study is part of the ‘‘Follow-Up of Transient ischemic
attack and stroke patients and Unelucidated Risk factor
Evaluation’’-study (FUTURE study). The design of the
FUTURE study has been described previously [7]. In short,
the FUTURE study is a prospective cohort study that aims
to investigate causes and consequences of young stroke.
The Medical Review Ethics Committee region Arnhem-
Nijmegen approved the study and we received consent
forms from all participants in the study.
Patients
The FUTURE study comprised all consecutive patients
with a TIA, IS or intracerebral hemorrhage (ICH), between
ages 18 and 50 years, admitted to the Radboud University
Medical Center Nijmegen, the Netherlands, from January
1, 1980 and November 1, 2010. Only surviving patients
with first-ever TIA or IS were included in the present study
because of the different pathophysiology underlying ICH.
To minimize bias due to changing diagnostic techniques,
the World Health Organization definition for TIA and
stroke was used [8, 9]. TIA was defined as a rapidly
evolving focal neurological deficit, without positive phe-
nomena such as twitches, jerks or myoclonus, with no other
than a vascular cause lasting less than 24 h. Stroke was
defined as focal neurological deficits persisting for more
than 24 h. On basis of radiological findings, stroke was
subdivided into ICH and IS.
Exclusion criteria were cerebral venous sinus thrombo-
sis and retinal infarction. For the present study we also
excluded patients from whom we could not obtain any of
the functional outcome measures at the second follow-up
moment in 2014–2015.
Patients were identified through a prospective registry of
all consecutive young stroke patients that has been main-
tained at the department since the 1970’ies [10] with a
standardized collection of baseline and clinical character-
istics (including demographics, stroke subtype and vascular
risk factors). Cardiovascular risk factors at baseline were
defined either as a history of a risk factor (mentioned in
medical history or the use of medication) or as a risk factor
detected during admission or analysis of the stroke as
follows: diabetes mellitus as a random blood glucose level
greater than 11.1 mmol/L or 2 consecutive fasting venous
plasma glucose levels of 7.0 mmol/L or greater [11];
hypertension as systolic blood pressure 135 mmHg or
greater and/or diastolic blood pressure 85 mmHg or
greater, measured after the first week of the index event;
and atrial fibrillation when identified on either an electro-
cardiogram or during continuous electrocardiographic
recording. Smoking was defined as smoking at least one
cigarette per day in the year prior to the event.
Furthermore all patients underwent a neurological
examination and brain imaging at the time of their index
event [7]. The assessment of both the etiology [modified
Trial of ORG 10172 in Acute Stroke Treatment (TOAST)
classification] [12] and severity (National Institutes of
Health Stroke Scale (NIHSS) [13]) at admission was done
for all cases retrospectively by a validated approach [14,
15], as these scales did not exist at the time when a sub-
stantial proportion of our patients experienced their quali-
fying event.
Follow-up
Information on the vital status was available either from the
hospital or via the municipality registry [16]. Patients alive
were invited for follow-up assessment consisting of ques-
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tionnaires between November 1, 2009 and January 1, 2012.
Subsequently, between August 1, 2014 and January 15,
2015 TIA and IS patients alive were approached by tele-
phone to assess their functional outcome [17] as well as
incident events using a standardized interview.
Functional outcome
Our primary outcome measure was the functional outcome
of patients at the second follow-up moment (2014–2015)
and the change in functional outcome from the first
(2009–2012) to the second follow-up wave. Functional
outcome was measured by the mRS [18]. This scale ranges
from perfect health without symptoms (0) to death (6). The
ability to carry out more complex activities was assessed
with the instrumental Activities of Daily Living scale
(iADL) [19, 20]. This scale assesses a person’s ability to
perform tasks such as using a telephone, doing laundry and
handling finances, and leads to a summary score ranging
from 0 to 8 (low to high function).
A poor functional outcome was defined as either a
mRS[ 2 or poor performance on the iADL as a score\8,
corresponding with dependency in daily life. Whereas we
used a common cut-off value for poor outcome on the mRS
([2) [21–23], there is no such commonly used cut-off
value for the iADL. However, loss of independence on any
iADL task is usually regarded as an impaired iADL [3, 24].
Therefore we have chosen a cut-off value of\8 to indicate
poor functional outcome. A deterioration in functional
outcome was regarded as a change from a good functional
outcome (mRS B 2/iADL = 8) to a poor functional out-
come (mRS[ 2/iADL\ 8).
Incident cardiovascular disease
The occurrence of an incident stroke (IS or ICH) or other
cardiovascular disease (cardiac disease, including
myocardial infarction, coronary artery bypass grafting and
percutaneous coronary intervention for coronary artery
disease, and peripheral artery disease) was assessed with a
standardized, structured questionnaire. Whenever an event
was suspected, information was retrieved from the treating
physicians and subsequently verified by specialists from
the appropriate field, who were blinded to both the index
event and functional outcome.
Statistical analysis
Differences in baseline characteristics between TIA and IS
patients were analyzed with Chi-square tests for categorical
variables, ANOVA or Kruskal–Wallis tests when appro-
priate. Descriptive statistics were used to describe the long-
term functional outcome (mRS/iADL) and the change in
functional outcome between the first and second follow-up
moment. Characteristics of patients with a poor functional
outcome and those who deteriorated were analysed with
Chi-square tests. We repeated this analysis stratified by time
of admission (before 1980, 1990–2000 and after 2000), by
age at baseline (\35, 35–45 and[45 years) and sex.
By means of logistic regression, we calculated odds
ratios (OR’s) with their corresponding 95 % confidence
intervals for the risk of poor outcome as assessed by the
mRS and the iADL. Covariates in the model were type of
index event (IS or TIA), sex, age at event, NIHSS at
admission, duration of follow-up, incident strokes and
incident cardiovascular disease. Two-sided p values of less
than 0.05 were considered to indicate statistical signifi-
cance. The statistical analysis was done using SPSS 20 for
Windows.
Results
For the present study, 619 patients with a first-ever TIA and
IS were included in the analysis (Fig. 1). Compared with
participants, patients who were lost to follow-up more often
had an IS (82.6 vs 68.3 %, p = 0.005), were slightly younger
[38.6 (SD 8.3) vs 40.9 (SD 7.7) years, p = 0.010] and less
often suffered from hypertension (18.5 vs 36.0 % patients,
p = 0.001) and diabetes mellitus (2.2 vs 8.4 %, p = 0.035).
Compared with participants, patients who refused to partic-
ipate were slightly younger [39.3 (SD 8.0) vs 40.9 (SD 7.7)
years, p = 0.017] and less often suffered from hypertension
(26.1 vs 36.0 %, p = 0.019); no differences in any of the
other baseline characteristics were found. The baseline
characteristics are presented in Table 1. During a mean
Fig. 1 Flow chart of the study population
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follow-up of 13.9 (SD 8.5) years 90 patients (14.5 %) suf-
fered from an incident stroke, of which 84 patients (93.3 %)
had an IS and 6 (6.7 %) an ICH.
Functional outcome
After a mean follow-up of 13.9 (SD 8.5) years, a poor
functional outcome on the mRS was present in 48 patients
(24.5 %) with a TIA and 189 patients (44.7 %) with an IS,
of whom 32 TIA patients and 135 IS patients had died at
follow-up (mRS = 6). There was a significant difference in
the proportion of patients with poor outcome between TIA
patients and IS patients (p\ 0.001). 118 Men (39.9 %) and
119 (36.8 %) women had a poor functional outcome on the
mRS (p = 0.490), although women were significantly
younger (39.7 vs 42.0 years, p = 0.001) and had a lower
NIHSS (median 2 vs 4, p = 0.003) than men.
At follow-up 25 patients (15.2 %) with TIA and 66
patients (22.9 %) with IS had a poor functional outcome on
the iADL. This did not significantly differ between TIA
and IS patients (p = 0.067). 34 Men (16.9 %) and 57
(22.7 %) women had a poor functional outcome on the
iADL (p = 0.159).
Transition in functional outcome
49 patients (11.5 %) deteriorated from good to poor func-
tional outcome between the first (2009–2011) and second
(2014–2015) follow-up, of whom 18 had died (Fig. 2). In
contrast, only five patients (1.3 %) improved from poor to
good functional outcome. Patients with deterioration did
not significantly differ in age at index event nor in the
decade in which their index event took place compared to
patients without deterioration. 12 Of these patients
(24.5 %) had suffered from a recurrent stroke compared to
78 patients (13.7 %) of the patients without deterioration
(p = 0.065). The number of these patients who suffered
from another incident vascular event was similar to patients
without deterioration (16.3 vs 14.4 %, p = 0.874). Women
more often deteriorated in functional outcome (as mea-
sured with the mRS) than men (10.5 vs 5.1 %, p = 0.018).
36 patients (10.3 %) who had an iADL of 8 at the first
follow-up moment (on average 5 years ago) now declined to
an iADL\ 8. Seven patients (15.6 %) with an iADL\ 8 at
the first follow-up moment improved to a good functional
outcome on the iADL. Women more often deteriorated with
regards to their functional outcome (iADL) (11.2 % in
women vs 6.7 % in men, p = 0.171), but this was not sig-
nificant. No significant differences in the proportion of
patients who had suffered from an incident event was seen
between patients with and without deterioration.
Risk factors
Table 2 shows the risk factors for poor functional outcome
in young TIA and IS patients. Multiple regression analysis
revealed that a poor functional outcome on the mRS was
predicted by female sex (OR 2.7; 95 % CI 1.5–5.0), higher
Table 1 Baseline
characteristics stratified by
stroke subtype
Total TIA IS p value
n (% of total) 619 (100) 196 (31.7) 423 (68.3)
Mean age at event, years (SD) 40.9 (7.7) 40.7 (8.0) 40.9 (7.6) 0.903
Men, n (%) 296 (47.8) 88 (44.9) 208 (49.2) 0.366
Median NIHSS at admission (IQR)a 3 (1–8) 0 (0–1) 5 (2–10) \0.001
Mean follow-up, years (SD) 13.9 (8.5) 12.3 (8.3) 14.7 (8.5) 0.002
Cardiovascular risk factors, n (%)
Hypertension 223 (36.0) 68 (34.7) 155 (36.6) 0.704
Diabetes mellitus 52 (8.4) 12 (6.1) 40 (6.5) 1 (2.5)
Atrial fibrillation 12 (1.9) 3 (1.5) 9 (2.1) n/a
Recent smokinga 306 (52.0) 78 (40.6) 228 (57.4) \0.001
TOAST classification, n (%)
Large artery 155 (25.0) 43 (21.9) 112 (26.5) 0.266
Cardio-embolism 81 (13.1) 26 (13.3) 55 (13.0) 1.000
Lacunar 62 (10.0) 11 (5.6) 51 (12.1) 0.019
Other determined 89 (14.4) 21 (10.7) 68 (16.1) 0.100
Multiple 17 (2.7) 2 (1.0) 15 (3.5) 0.127
Undetermined 215 (34.7) 93 (47.4) 122 (28.8) \0.001
NIHSS National Institutes of Health Stroke Scale, IQR interquartile range, TOAST classification modified
Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification
a In 0.5 % of the patients NIHSS at admission and in 4.8 % smoking status was missing
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age at stroke onset (OR 1.0; 95 % CI 1.0–1.1 per year),
higher NIHSS at admission (OR 1.2; 95 % CI 1.1–1.2 per
point increase) and the occurrence of an incident stroke
(OR 5.7; 95 % CI 2.9–11.2). A poor functional outcome on
the iADL was predicted by female sex (OR 2.0; 95 % CI
1.2–3.4), a higher NIHSS at admission (OR 1.2; 95 % CI
1.1–1.3 per point increase) and the occurrence of an inci-
dent stroke (OR 5.0; 95 % CI 2.6–9.6).
The proportion of patients with a poor functional out-
come was 61.6, 47.0 and 23.7 %, depending on the decade
of their index event (before 1990, between 1990 and 2000
and after 2000; p\ 0.001 for overall difference). In
patients aged\30, 30–40 and[45 years at the time of their
index event the proportion with a poor functional outcome
was 27.3, 33.1 and 42.7 % (p = 0.015 for overall differ-
ence). Between these groups there were no differences in
outcome as assessed by the iADL.
Discussion
We showed that on average 14 years after an ischemic
stroke in a young adult almost one out of five long-term
survivors (18.8 %) was not able to function independently
based on the mRS. In surviving TIA patients this is one
out of ten patients (9.8 %). About 1 out of 8 (11.5 %) of
the surviving patients with a good functional outcome
during the first follow up (on average 10 years after the
qualifying event) lost independency in daily life or died
during the second follow up (on average 14 years after the
event). In contrast, almost one out of six (15.6 %) of the
very long time survivors improved to a good functional
outcome on the iADL in comparison to the first follow-up
moment.
The strength of our study was the long follow-up
duration, which is the longest follow-up reported in the
field of young stroke, and the ability to detect change in
prognosis due to repeated follow-up assessments which
enabled us to give more accurate information about the
very long-term prognosis after stroke at young age. In
addition, our study had a prospective and single center
design, which allowed us to collect information systemat-
ically and to uniformly verify both the index event as well
as the outcome, thereby reducing the risk of information
bias, although a single center design could limit the gen-
eralizability slightly in comparison to multi-center designs.
However, the risk of this is low, therefore we consider it
likely that our results can be generalized to most of the
Fig. 2 Change of modified Rankin scale scores from first to second follow-up wave (n = 619). The upper bar represents the mRS data obtained
during the first follow-up (2009–2011). The lower bar represents data obtained during the second follow-up (2014–2015)
Table 2 Predictors of a poor
functional outcome in young
TIA and IS patients
mRS[ 2 iADL\ 8
OR (95 % CI) p value OR (95 % CI) p value
Ischemic strokea 0.8 (0.4–1.6) 0.537 0.6 (0.3–1.1) 0.099
Female sex 2.7 (1.5–5.0) 0.001 2.0 (1.2–3.4) 0.013
Age at baseline 1.0 (1.0–1.1) 0.026 1.0 (1.0–1.1) 0.118
NIHSS at admission (per point increase) 1.2 (1.1–1.2) \0.001 1.2 (1.1–1.3) \0.001
Incident stroke 5.7 (2.9–11.2) \0.001 5.0 (2.6–9.6) \0.001
Incident cardiovascular diseaseb 1.1 (0.5–2.4) 0.863 1.0 (0.5–2.2) 0.984
Duration of follow-up (years) 1.0 (1.0–1.1) 0.212 1.0 (1.0–1.0) 0.432
a TIA patients serve as the reference group
b Incident cardiovascular disease: incident cardiac disease and/or peripheral artery disease
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young stroke population, especially those who are already
months to years past their initial stroke.
However, there are also some limitations. Selection bias
may have occurred due to selective loss to follow-up. Both
patients lost to follow-up and refusers suffered substan-
tially more often from hypertension at baseline. Therefore
non-participants possibly were at a higher risk of incident
events and thus an increased risk of a poor functional
outcome. Our findings therefore most likely represent an
underestimation of the true long-term functional prognosis
after stroke in young adults. In addition, possibly not all
deficits reported in either of the questionnaires were caused
by direct effects of the index stroke, since comorbidity can
also lead to the inability to function independently. How-
ever, irrespective of the disease underlying the loss of
independence, it is remarkable to note the large proportion
of still young patients that require help in daily life, on
average 14 years after stroke. Finally, during the long
inclusion window there have been considerable changes in
stroke care, possible resulting in changes in prognosis after
stroke at young age as well. We did show a worse prog-
nosis in patients who were admitted with their index event
longer ago, however, it cannot be concluded that this is
(entirely) due to these changes in care, since these patients
also have been at risk to develop recurrent events and
comorbidities for a longer period of time.
In previous studies, poor functional outcome in young IS
patients ranged from 3 to 7 % after mean follow-up dura-
tion between 4 and 12 years [21, 25, 26], better than in our
study. This could partly be explained by inclusion of older
patients (up to 50 instead of 45 years of age) in our study.
Furthermore, in these previous studies functional outcome
was measured only by either the mRS or the Glasgow
Outcome Scale (GOS), which are commonly used, but are
rather global scales for outcome. We intentionally used an
additional, complimentary method to determine functional
outcome. The iADL (only for survivors) takes into account
the ability to perform very specific tasks relevant for living
independently, whereas the mRS is a functional outcome
measure that is very much dependent on motor perfor-
mance. These tasks not only rely upon physical health, but
also require cognitive function at some level [27]. Conse-
quently the use of these cut-offs of these different scales
will result in different groups.
‘Statistics Netherlands’ published data on disabilities in
the general Dutch population [28]. Unfortunately the iADL
scale is only reported in patients over 55 years of age.
However, they do provide information on disability on an
OESO-scale, which gives quite a similar impression of
disability as the iADL scale. Items on this OESO-scale are
walking unaided by another person for 400 m, taking part
in a conversation, reading a paper, carrying groceries,
picking up an item from the floor. They report that 14.0 %
of people between 50 and 55 years (the average age of our
patients at follow-up) experience problems on at least one
of the items of this scale (in our study 15.2 % of TIA
patients and 22.9 % of IS patients experienced problems in
iADL). Younger people experience this in B7.1 % of the
cases. Although this is not a case controlled study, espe-
cially IS patients have a much higher (50 %) risk of dis-
ability than individuals from the general population.
Finally, we attempted to identify risk factors for long-
term poor functional outcome. Interestingly, women had a
two to threefold higher risk of a poor outcome than men.
This sex-difference in long-term functional outcome after
stroke has previously been described in the elderly stroke
population [2, 6, 29]. It is assumed that the sex-differences
could be (partially) explained by a more advanced age,
poorer prestroke functionality, more comorbidities, a ten-
dency to suffer from more severe strokes and less social
support in women in comparison to male stroke patients [2,
6, 29]. In our study we observed the increased risk of poor
outcome in women despite adjusting for stroke severity,
age at initial stroke and the presence of incident events,
implying that other underlying mechanisms are involved.
There is ongoing research to identify biological mecha-
nisms clarifying the sex-differences in stroke patients,
which mainly focuses on the role of sex steroid hormones
[29].
Providing patients and relatives with information is an
important aspect of clinical practice. Therefore, it is
important to realise that female sex and the initial stroke
severity are the strongest baseline determinants of poor
long-term functional outcome. In addition, higher age at
the time of the index event is associated with an increased
risk of poor functional outcome. These parameters are
objective, easy to assess and readily available in the acute
phase. Patients and their caregivers should be informed
about the long-term prognosis to give them the opportunity
to make educated choices about career moves and family
planning.
In conclusion, the very long-term functional prognosis
after young stroke is worse than previously assumed. Up to
one out of five young ischemic stroke survivors is not able
to live independently almost 14 years after stroke. In
addition, very long-term poor functional prognosis was
seen in almost one out of ten young TIA survivors. This is
important information for patients, their caregivers and for
health professionals when counselling their patients on the
course of the disease. In addition, the continuous decline in
functional outcome long after the initial stroke seen in our
population suggests that long-term care and follow-up is
needed for young stroke patients. Further research is nee-
ded to clarify the etiology and to identify explanations of
the observed sex differences of the ongoing decline in
young stroke patients and to assess whether additional
1104 J Neurol (2016) 263:1099–1105
123
preventive strategies could decrease the proportion of
patients with late deterioration.
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